CN102660510B - A kind of method utilizing bio-reactor to produce transmissible gastro-enteritis virus - Google Patents

A kind of method utilizing bio-reactor to produce transmissible gastro-enteritis virus Download PDF

Info

Publication number
CN102660510B
CN102660510B CN201210141452.2A CN201210141452A CN102660510B CN 102660510 B CN102660510 B CN 102660510B CN 201210141452 A CN201210141452 A CN 201210141452A CN 102660510 B CN102660510 B CN 102660510B
Authority
CN
China
Prior art keywords
virus
cell
microcarrier
cells
reactor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210141452.2A
Other languages
Chinese (zh)
Other versions
CN102660510A (en
Inventor
于萍萍
王贵华
侯艳红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhaofenghua Biotechnology Fuzhou Co ltd
Zhaofenghua Biotechnology Nanjing Co ltd
Beijing Dabeinong Biotechnology Co Ltd
Original Assignee
FUZHOU DA BEI NONG BIOTECH Co Ltd
Beijing Dabeinong Technology Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUZHOU DA BEI NONG BIOTECH Co Ltd, Beijing Dabeinong Technology Group Co Ltd filed Critical FUZHOU DA BEI NONG BIOTECH Co Ltd
Priority to CN201210141452.2A priority Critical patent/CN102660510B/en
Publication of CN102660510A publication Critical patent/CN102660510A/en
Application granted granted Critical
Publication of CN102660510B publication Critical patent/CN102660510B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明提供一种利用生物反应器生产猪传染性胃肠炎病毒的方法,包括如下步骤:1)制备单层传代细胞;2)制备猪传染性胃肠炎病毒生产用种毒;3)将步骤1)制备的单层传代细胞制备成细胞悬液,接种到生物反应器内,使传代细胞在生物反应器中的微载体上吸附培养;4)当传代细胞长至微载体的80%-90%,空球率低于5%,满球率大于80%,细胞计数达到3-5×106个/mL以上时,以2-5%的接种量接种步骤2)制备的种毒,进行病毒的吸附培养;4)当微载体上的传代细胞80%以上病变时,收获病毒液。本发明方法可解决生产效率低、产品质量不稳定、病毒效价低的问题,可提高病毒单位培养效价5-10倍,全面提升疫苗质量和产量,提高疫苗的安全性。The invention provides a method for producing porcine transmissible gastroenteritis virus by using a bioreactor, comprising the following steps: 1) preparing monolayer passage cells; 2) preparing seed poison for porcine transmissible gastroenteritis virus production; 3) preparing porcine transmissible gastroenteritis virus Step 1) The monolayer passaged cells prepared are prepared into a cell suspension, inoculated into a bioreactor, and the passaged cells are adsorbed and cultivated on the microcarriers in the bioreactor; 4) when the passaged cells grow to 80% of the microcarriers- 90%, the empty ball rate is less than 5%, the full ball rate is greater than 80%, and when the cell count reaches 3-5×10 6 cells/mL or more, inoculate the seed virus prepared in step 2) with an inoculation amount of 2-5%, Carry out the adsorption culture of the virus; 4) when more than 80% of the passaged cells on the microcarriers are diseased, the virus liquid is harvested. The method of the invention can solve the problems of low production efficiency, unstable product quality and low virus titer, can increase the virus unit culture titer by 5-10 times, comprehensively improve the quality and yield of vaccines, and improve the safety of vaccines.

Description

一种利用生物反应器生产猪传染性胃肠炎病毒的方法A method for producing porcine transmissible gastroenteritis virus using a bioreactor

技术领域 technical field

本发明涉及一种病毒的生产方法,具体地,涉及一种猪传染性胃肠炎病毒的生产方法,更具体地,涉及一种利用生物反应器生产猪传染性胃肠炎病毒的方法。The invention relates to a method for producing a virus, in particular to a method for producing porcine transmissible gastroenteritis virus, and more specifically to a method for producing porcine transmissible gastroenteritis virus by utilizing a bioreactor.

背景技术 Background technique

猪传染性胃肠炎(PorcineTransmissibleGastroenteritis,TGE)是由冠状病毒科(Coronaviridae)、冠状病毒属(Coronavirus)的猪传染性胃肠炎病毒(PorcineTransmissibleGastroenteritisvirus,TGEV)引起的以猪呕吐、腹泻、脱水为特征的传染病,对新生仔猪具有高度致死率,通常为100%。虽然不同年龄的猪对这种病毒均易感,但5周龄以上的猪感染后,死亡率很低。Doyle于1945年报道美国首次发生该病后,世界上许多国家都相继报道了猪传染性胃肠炎,1956年我国广东首次发生该病后,全国大多省份也有发生,给养猪业带来了严重危害。Porcine transmissible gastroenteritis (Porcine Transmissible Gastroenteritis, TGE) is caused by porcine transmissible gastroenteritis virus (Porcine Transmissible Gastroenteritis virus, TGEV) of Coronaviridae (Coronaviridae) and Coronavirus (Coronavirus), characterized by pig vomiting, diarrhea, and dehydration An infectious disease that has a high lethality rate for newborn piglets, usually 100%. Although pigs of different ages are susceptible to the virus, pigs older than 5 weeks have a low mortality rate after infection. After Doyle reported that the disease first occurred in the United States in 1945, many countries in the world have reported porcine transmissible gastroenteritis one after another. After the disease first occurred in Guangdong, my country in 1956, it also occurred in most provinces of the country, which brought great harm to the pig industry. Serious harm.

目前,国内猪传染性胃肠炎疫苗生产唯一依靠细胞转瓶培养法实现。该传统工艺劳动强度大,耗时长、效率低,生产成本高;容易被环境污染;不同生产批次间或同一生产批次不同瓶间的差异大;难以扩大生产;容易出现被细菌或其它病毒污染而致的疫苗质量隐患,涉及生物安全和公共卫生问题。At present, the production of porcine transmissible gastroenteritis vaccine in China only relies on the cell spinner bottle culture method. The traditional process is labor-intensive, time-consuming, low in efficiency, and high in production cost; it is easy to be polluted by the environment; there are large differences between different production batches or between different bottles of the same production batch; it is difficult to expand production; it is easy to be contaminated by bacteria or other viruses The hidden dangers of vaccine quality caused by this problem involve biosafety and public health issues.

发明内容 Contents of the invention

为了解决上述问题,本发明提供一种利用生物反应器生产猪传染性胃肠炎病毒的方法。In order to solve the above problems, the present invention provides a method for producing porcine transmissible gastroenteritis virus using a bioreactor.

本发明提供的方法,包括如下步骤:The method provided by the invention comprises the steps of:

1)制备单层传代细胞;1) Prepare monolayer passage cells;

2)制备猪传染性胃肠炎病毒生产用种毒;2) preparing porcine transmissible gastroenteritis virus seed virus for production;

3)将步骤1)制备的单层传代细胞消化后,用细胞生长液进行悬浮,制备成细胞密度为1-3×105个/mL的细胞悬液,接种到生物反应器内,使传代细胞在生物反应器中的微载体上吸附培养;3) Digest the monolayer passaged cells prepared in step 1), suspend them with cell growth medium, prepare a cell suspension with a cell density of 1-3×10 5 cells/mL, inoculate them into a bioreactor, and make the passaged cells Cells are adsorbed and cultured on microcarriers in a bioreactor;

4)当传代细胞长至微载体的80%-90%,空球率低于5%,满球率大于80%,细胞计数达到3-5×106个/mL以上时,以2-5%的接种量接种步骤2)制备的种毒,进行病毒的吸附培养;4) When the passaged cells grow to 80%-90% of the microcarrier, the empty ball rate is lower than 5%, the full ball rate is greater than 80%, and the cell count reaches 3-5×10 6 cells/mL or more, use 2-5 % inoculum amount inoculates the seed virus prepared in step 2), and carries out the adsorption culture of the virus;

4)当微载体上的传代细胞80%以上病变时,收获病毒液。4) When more than 80% of the passaged cells on the microcarriers are diseased, the virus liquid is harvested.

其中,所述方法还包括在步骤3)中的细胞悬液接种到生物反应器之前,按生物反应器总体积的50-70%加入无菌细胞生长液,且每升无菌细胞生长液中按4-10g/L浓度加入微载体,启动生物反应器,低转速搅拌20-50分钟。Wherein, the method also includes adding sterile cell growth liquid according to 50-70% of the total volume of the bioreactor before the cell suspension in step 3) is inoculated into the bioreactor, and every liter of sterile cell growth liquid Add microcarriers at a concentration of 4-10g/L, start the bioreactor, and stir at low speed for 20-50 minutes.

其中,所述的方法还包括将微载体加入到细胞生长液之前将微载体进行清洗和灭菌的步骤,依次为用PBS浸泡微载体3小时以上;用PBS清洗微载体3-5遍;用PBS浸泡微载体,121℃蒸汽灭菌20-50min。Wherein, the method also includes the steps of cleaning and sterilizing the microcarriers before adding the microcarriers to the cell growth solution, followed by soaking the microcarriers with PBS for more than 3 hours; washing the microcarriers with PBS for 3-5 times; Soak microcarriers in PBS and steam sterilize at 121°C for 20-50min.

其中,步骤2)猪传染性胃肠炎病毒生产用种毒的制备具体包括如下步骤:Wherein, step 2) the preparation of seed virus for porcine transmissible gastroenteritis virus production specifically includes the following steps:

用病毒培养液将猪传染性胃肠炎病毒种毒按2-5%比例接种到单层传代细胞中进行培养,至细胞80%以上病变时收获病毒液;再将此病毒液作为种毒,在细胞上进行细胞适应性连续传代复壮,每次传代产物进行病毒TCID50和无菌检测,传至病毒TCID50稳定且达到107TCID50/mL以上时停止复壮,作为生产用种毒。其中,所述的病毒培养液可为本领域常规的病毒培养液,优选的配方为:质量分数分别是98%-99%MEM液、1%-2%牛血清、终浓度为100-200IU/mL的抗菌素,pH值为6.8-7.5。Inoculate porcine transmissible gastroenteritis virus seed virus into single-layer passage cells at a ratio of 2-5% with virus culture liquid for cultivation, and harvest the virus liquid when more than 80% of the cells are diseased; then use this virus liquid as the seed virus, Carry out cell adaptive continuous passage and rejuvenation on the cells, and the virus TCID 50 and sterility test are carried out for each passage product, and the rejuvenation is stopped when the virus TCID 50 is stable and reaches more than 10 7 TCID 50 /mL, and used as a seed virus for production. Wherein, the virus culture solution can be a conventional virus culture solution in the field, and the preferred formula is: the mass fraction is 98%-99% MEM solution, 1%-2% bovine serum, and the final concentration is 100-200IU/ mL of antibiotics, pH 6.8-7.5.

其中,步骤3)中的单层传代细胞用EDTA-胰酶消化液进行消化,所述的EDTA-胰酶消化液为含有质量体积分数为0.05%-0.25%的胰酶和0.02%的EDTA的Hank’S液。Wherein, the monolayer passaged cells in step 3) are digested with EDTA-trypsin digestion solution, and the EDTA-trypsin digestion solution is containing 0.05%-0.25% trypsin and 0.02% EDTA in mass volume fraction Hank'S liquid.

其中,步骤3)中所述的细胞悬液中传代细胞的密度为1-3×105个/mL。Wherein, the density of passaged cells in the cell suspension described in step 3) is 1-3×10 5 cells/mL.

其中,步骤3)中所述的细胞生长液的配方为:质量分数为95%-98%MEM液、2%-5%牛血清、终浓度为100-200IU/mL的抗菌素,pH值为6.8-7.5。Wherein, the formula of the cell growth liquid described in step 3) is: the mass fraction is 95%-98% MEM liquid, 2%-5% bovine serum, the antibiotic of final concentration is 100-200IU/mL, and pH value is 6.8 -7.5.

其中,所述的传代细胞可为本领域中常规用于病毒培养的细胞,优选为ST细胞或vero细胞,最优选为ST细胞。Wherein, the passaged cells may be cells routinely used for virus culture in the art, preferably ST cells or vero cells, most preferably ST cells.

本发明中,生物反应器设定的参数优选为:培养温度35-38℃、pH值6.8-7.5、溶氧50%-70%、搅拌速度50-80rpm。In the present invention, the parameters set in the bioreactor are preferably: cultivation temperature 35-38°C, pH value 6.8-7.5, dissolved oxygen 50%-70%, stirring speed 50-80rpm.

其中,所述的猪传染性胃肠炎病毒可为任何常规的猪传染性胃肠炎病毒毒株,优选为浮羽疫苗株、h-5疫苗株或华毒株。Wherein, the porcine transmissible gastroenteritis virus can be any conventional strain of porcine transmissible gastroenteritis virus, preferably a floating feather vaccine strain, h-5 vaccine strain or Sinovirus strain.

其中,所述的微载体可为本领域常规的任何微载体,常见的有大孔明胶微载体、聚苯乙烯微载体、PHEMA微载体、甲壳质微载体、聚氨酯泡沫微载体、藻酸盐凝胶微载体、磁性微载体、Cytodex1、Cytodex2、Cytodex3、Cytopore和/或Cytoline,优选为Cytodex1、Cytodex2、Cytodex3、Cytopore和/或Cytoline。Wherein, the microcarriers can be any conventional microcarriers in the art, such as macroporous gelatin microcarriers, polystyrene microcarriers, PHEMA microcarriers, chitin microcarriers, polyurethane foam microcarriers, alginate gel microcarriers, etc. Gel microcarriers, magnetic microcarriers, Cytodex1, Cytodex2, Cytodex3, Cytopore and/or Cytoline, preferably Cytodex1, Cytodex2, Cytodex3, Cytodex and/or Cytoline.

与现有技术相比,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:

(1)用生物反应器微载体细胞培养技术代替转瓶细胞培养技术制造猪传染性胃肠炎病毒疫苗,可解决生产效率低、产品质量不稳定、病毒效价低的问题,通过生产技术和生产工艺的改变,提高病毒单位培养效价5-10倍,全面提升疫苗质量和产量,提高疫苗的安全性。以vero细胞为例,国内先进水平的生物反应器生产可达107/mL,而转瓶生产一般106/mL已经为极限。(1) Using bioreactor microcarrier cell culture technology instead of spinner bottle cell culture technology to manufacture porcine transmissible gastroenteritis virus vaccine can solve the problems of low production efficiency, unstable product quality and low virus titer. Through production technology and The change of the production process can increase the virus unit culture titer by 5-10 times, comprehensively improve the quality and yield of the vaccine, and improve the safety of the vaccine. Taking vero cells as an example, domestic advanced bioreactor production can reach 10 7 /mL, while spinner bottle production is generally 10 6 /mL is already the limit.

(2)本发明可以大量降低生产成本,而且生产周期短,每个生产周期仅需5-6天,相比现有转瓶细胞培养法的6-7天以上明显缩短。(2) The present invention can greatly reduce the production cost, and the production cycle is short, and each production cycle only needs 5-6 days, which is significantly shorter than the 6-7 days of the existing spinner bottle cell culture method.

(3)低污染:1罐=100~2000个转瓶,概率来讲操作环节越少污染几率越低。(3) Low pollution: 1 can = 100-2000 spinner bottles, the probability is that the fewer the operation links, the lower the probability of pollution.

(4)生产工艺可控:高精密培养、实时监测溶氧、产气、PH、细胞状态等等,综合参数设定培养曲线、直接保证载体细胞的状态;批量大、批间差小;节省空间、人员(最高可达1∶75);一旦成型工艺将按部就班十分稳定。(4) The production process is controllable: high-precision culture, real-time monitoring of dissolved oxygen, gas production, PH, cell status, etc., comprehensive parameter setting of the culture curve, directly ensuring the status of the carrier cells; large batches, small differences between batches; saving Space, personnel (up to 1:75); once the molding process will be very stable step by step.

附图说明 Description of drawings

图1为本发明利用生物反应器生产猪传染性胃肠炎病毒的方法流程图。Fig. 1 is a flow chart of the method for producing porcine transmissible gastroenteritis virus using a bioreactor according to the present invention.

具体实施方式 detailed description

以下实施例用于说明本发明,但不用来限制本发明的范围。The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.

实施例1Example 1

(1)选择生物反应器作为培养的手段:7L瑞士Lambda生物反应器。(1) Choose a bioreactor as the means of cultivation: 7L Swiss Lambda bioreactor.

(2)选择微载体作为细胞贴附生长的载体:微载体Cytodex2。(2) Select the microcarrier as the carrier for cell attachment and growth: microcarrier Cytodex2.

(3)微载体的清洗、灭菌方法:1)称量Cytodex2微载体10g/L、使用2LPBS液浸泡3小时。2)每次用2LPBS液清洗3遍。3)加入2LPBS液浸泡微载体,121℃蒸汽灭菌30min。(3) Cleaning and sterilization methods of microcarriers: 1) Weigh 10 g/L of Cytodex2 microcarriers and soak in 2LPBS solution for 3 hours. 2) Wash 3 times with 2LPBS each time. 3) Add 2LPBS solution to soak the microcarriers, and steam sterilize at 121° C. for 30 minutes.

(4)选择ST细胞作为制苗用细胞。(4) Select ST cells as cells for making seedlings.

(5)制苗用细胞的传代与培养:上述细胞经EDTA-胰酶(含0.25%胰酶、0.02%EDTA的Hank’S液)消化传代,以含95%MEM液、5%小牛血清、200IU/mL的青霉素钠和硫酸链霉素,pH值调整为7.2的细胞生长液继续培养,培养温度为37℃。形成良好单层时,用于接种于生物反应器中进行微载体悬浮培养。(5) Passaging and culturing of cells for seedling preparation: the above-mentioned cells were digested and passaged by EDTA-trypsin (Hank'S solution containing 0.25% trypsin and 0.02% EDTA), and then prepared with 95% MEM solution, 5% calf serum, 200IU /mL of penicillin sodium and streptomycin sulfate, the pH value of the cell growth medium was adjusted to 7.2, and the culture temperature was 37°C. When a good monolayer is formed, it is used to inoculate in a bioreactor for microcarrier suspension culture.

(6)细胞毒种的繁殖:用病毒培养液(含小牛血清2%的MEM液、终浓度为200IU/mL的青霉素钠和硫酸链霉素,将猪传染性胃肠炎病毒华毒株的种毒按体积比2%比例接种生长良好的上述细胞单层,继续培养,培养温度为35℃。至细胞80%以上病变时收获病毒液;测定病毒的TCID50,待病毒效价稳定且达到107TCID50/mL以上时停止复壮,将该病毒作为生产用种毒。(6) Propagation of cytotoxic species: with virus culture fluid (containing 2% MEM liquid of calf serum, penicillin sodium and streptomycin sulfate that the final concentration is 200IU/mL, porcine transmissible gastroenteritis virus Hua strain The seed virus was inoculated into the above-mentioned well-grown cell monolayer according to the ratio of 2% by volume, and continued to cultivate at a temperature of 35°C. Harvest the virus liquid when more than 80% of the cells were diseased; measure the TCID 50 of the virus, and wait until the virus titer is stable and Rejuvenation was stopped when it reached above 10 7 TCID 50 /mL, and the virus was used as a seed virus for production.

(7)ST在生物反应器中的微载体悬浮培养:取方瓶上生长良好的ST细胞,用pH值为7.2的PBS清洗一遍,加入前述的EDTA-胰酶消化液消化,待细胞层开始出现整片脱落,加入所述的细胞生长液,吹悬制成细胞悬浮液,细胞计数密度按2×105/mL接种反应器中。生物反应器设定如下参数温度37℃、pH值7.2、搅拌速度60rpm、溶氧含量50%进行反应器自动控制培养。(7) Microcarrier suspension culture of ST in a bioreactor: take well-grown ST cells on a square bottle, wash them once with PBS with a pH value of 7.2, add the aforementioned EDTA-trypsin digestion solution for digestion, and wait for the cell layer to start If the whole piece falls off, add the above-mentioned cell growth solution, blow and suspend to make a cell suspension, and inoculate the reactor at a cell density of 2×10 5 /mL. The bioreactor was set with the following parameters: temperature 37° C., pH value 7.2, stirring speed 60 rpm, dissolved oxygen content 50%, and the reactor was automatically controlled for cultivation.

(8)制苗毒液的繁殖:培养后第三日待观察微载体上细胞基本长满(95%以上),且细胞计数结果达4×106/mL以上后,按体积比为2%接种病毒。设定温度34℃、pH值6.8、搅拌速度70rpm、溶氧含量30%等培养参数,进行反应器自动控制培养。接毒后每隔一定时间取反应器中微载体,用显微镜观察细胞病变情况,并检测样品的TCID50。待观察微载体上细胞基本全部脱落(约36h),且DO值明显上升趋势,停止反应器搅拌,待微载体全部沉到反应器底部后,分别收获上清液和微载体。(8) Propagation of seedling venom: on the third day after cultivation, observe that the cells on the microcarriers are basically overgrown (over 95%), and after the cell counting result reaches over 4×10 6 /mL, inoculate at 2% by volume Virus. The culture parameters such as temperature 34°C, pH value 6.8, stirring speed 70rpm, dissolved oxygen content 30% were set, and the reactor was automatically controlled for cultivation. After inoculation, the microcarriers in the reactor were taken at regular intervals, the cell pathological changes were observed with a microscope, and the TCID 50 of the samples was detected. To observe that the cells on the microcarriers are basically all shedding (about 36h), and the DO value is obviously rising, stop the reactor stirring, and after the microcarriers all sink to the bottom of the reactor, harvest the supernatant and the microcarriers respectively.

收获病毒液的处理:收获上清经3次反复冻融后,过滤去除细胞碎片后-20℃冷冻保存备用。Processing of harvested virus liquid: after 3 times of repeated freezing and thawing, the harvested supernatant was filtered to remove cell debris and then frozen at -20°C for later use.

实施例2Example 2

(1)选择生物反应器作为培养的手段:7L瑞士Lambda生物反应器。(1) Choose a bioreactor as the means of cultivation: 7L Swiss Lambda bioreactor.

(2)选择微载体作为细胞贴附生长的载体:微载体Cytodex3。(2) Select the microcarrier as the carrier for cell attachment and growth: microcarrier Cytodex3.

(3)微载体的清洗、灭菌方法:1)称量Cytodex3微载体6g/L、使用2LPBS液浸泡3小时。2)每次用2LPBS液清洗3遍。3)加入2LPBS液浸泡微载体,121℃蒸汽灭菌30min。(3) Cleaning and sterilization methods of microcarriers: 1) Weigh Cytodex3 microcarriers at 6 g/L and soak in 2 LPBS solution for 3 hours. 2) Wash 3 times with 2LPBS each time. 3) Add 2LPBS solution to soak the microcarriers, and steam sterilize at 121° C. for 30 minutes.

(4)选择vero细胞作为制苗用细胞。(4) Select vero cells as cells for seedling production.

(5)制苗用细胞的传代与培养:上述细胞经EDTA-胰酶(含0.25%胰酶、0.02%EDTA的Hank’S液)消化传代,以含96%MEM液、4%小牛血清、200IU/mL的青霉素钠和硫酸链霉素,pH值调整为7.2的细胞生长液继续培养,培养温度为37℃。形成良好单层时,用于接种于生物反应器中进行微载体悬浮培养。(5) Passaging and culturing of cells for seedling preparation: the above-mentioned cells were digested and passaged by EDTA-trypsin (Hank'S solution containing 0.25% trypsin and 0.02% EDTA), and then prepared with 96% MEM solution, 4% calf serum, 200IU /mL of penicillin sodium and streptomycin sulfate, the pH value of the cell growth medium was adjusted to 7.2, and the culture temperature was 37°C. When a good monolayer is formed, it is used to inoculate in a bioreactor for microcarrier suspension culture.

(6)细胞毒种的繁殖:用病毒培养液(含小牛血清1%的MEM液、终浓度为100IU的青霉素钠和硫酸链霉素,pH值调整为7.3),将猪传染性胃肠炎病毒华毒株的种毒按体积比为5%比例接种生长良好的上述细胞单层,继续培养,培养温度为35℃。至细胞80%以上病变时收获病毒液;测定病毒的TCID50,待病毒效价稳定且达到107TCID50/mL以上时停止复壮,将该病毒作为生产用种毒。(6) Propagation of cytotoxic species: pig infectious gastrointestinal Inoculate the well-growing monolayer of the above-mentioned cells with 5% volume ratio of the seed virus of the Hua strain of phlogiston virus, and continue culturing at a temperature of 35°C. Harvest the virus liquid when more than 80% of the cells are diseased; measure the TCID 50 of the virus, and stop rejuvenation when the virus titer is stable and reaches more than 10 7 TCID 50 /mL, and use the virus as a seed virus for production.

(7)vero细胞在生物反应器中的微载体悬浮培养:取方瓶上生长良好的vero细胞,用pH值为7.2的PBS清洗一遍,加入前述的EDTA-胰酶消化液消化,待细胞层开始出现整片脱落,加入所述的细胞生长液,吹悬制成细胞悬浮液,细胞计数密度按1×105/mL接种反应器中。生物反应器设定如下参数温度37℃、pH值7.2、搅拌速度60rpm、溶氧含量50%进行反应器自动控制培养。(7) Microcarrier suspension culture of vero cells in a bioreactor: take the well-grown vero cells on the square bottle, wash them once with PBS with a pH value of 7.2, add the aforementioned EDTA-trypsin digestion solution for digestion, and wait for the cell layer When the entire sheet begins to fall off, the cell growth solution is added, and the cell suspension is formed by blowing, and the cell count density is 1×10 5 /mL and inoculated into the reactor. The bioreactor was set with the following parameters: temperature 37° C., pH value 7.2, stirring speed 60 rpm, and dissolved oxygen content 50% to carry out automatic reactor control cultivation.

(8)制苗毒液的繁殖:培养后第三日待观察微载体上细胞基本长满(95%以上),且细胞计数结果达5×106/mL以上后,按体积比为2%进行病毒接种。设定温度38℃、pH值7.5、搅拌速度50rpm、溶氧含量50%等培养参数,进行反应器自动控制培养。两天后收获病毒液。收获病毒液的处理:收获上清经3次反复冻融后,过滤去除细胞碎片后-20℃冷冻保存备用。(8) Propagation of seedling venom: after the third day of cultivation, observe that the cells on the microcarrier are basically overgrown (over 95%), and after the cell counting result reaches more than 5×10 6 /mL, proceed with a volume ratio of 2%. Viral inoculation. Set the culture parameters such as temperature at 38°C, pH value at 7.5, stirring speed at 50 rpm, and dissolved oxygen content at 50% to carry out reactor automatic control culture. The virus fluid was harvested two days later. Processing of harvested virus liquid: after 3 times of repeated freezing and thawing, the harvested supernatant was filtered to remove cell debris and then frozen at -20°C for later use.

对比例1转瓶培养猪传染性胃肠炎病毒Comparative Example 1 Spinner bottle cultivation of porcine transmissible gastroenteritis virus

(1)选择转瓶作为培养的手段:3L细胞培养转瓶,ZP-01-16转瓶机。(1) Choose spinner bottle as the means of culture: 3L cell culture spinner bottle, ZP-01-16 spinner bottle machine.

(2)选择vero细胞作为制苗用细胞。(2) Select vero cells as cells for seedling production.

(3)制苗用细胞的传代与培养:上述细胞经EDTA-胰酶(含0.25%胰酶、0.02%EDTA的Hank’S液)消化传代,以含95%MEM液、5%小牛血清、200IU/mL的青霉素钠和硫酸链霉素,pH值调整为7.2的细胞生长液继续培养,培养温度为37℃。形成良好单层时,用于接种于转瓶培养。(3) Passaging and culturing of cells for seedling preparation: the above-mentioned cells were digested and passaged by EDTA-trypsin (Hank'S solution containing 0.25% trypsin and 0.02% EDTA), and then prepared with 95% MEM solution, 5% calf serum, 200IU /mL of penicillin sodium and streptomycin sulfate, the pH value of the cell growth medium was adjusted to 7.2, and the culture temperature was 37°C. When a good monolayer is formed, it is used for inoculation in roller bottle culture.

(4)细胞毒种的繁殖:用病毒培养液(含血清1%的MEM液、终浓度为200IU的青霉素钠和硫酸链霉素,pH值调整为7.3),将猪传染性胃肠炎病毒华毒株的种毒按体积比为5%比例接种生长良好的上述细胞单层,继续培养,培养温度为35℃。至细胞80%以上病变时收获病毒液;测定病毒的TCID50,待病毒效价稳定且达到107TCID50/mL以上时停止复壮,将该病毒作为生产用种毒。(4) Propagation of cytotoxic species: with virus culture fluid (containing the MEM liquid of serum 1%, the penicillin sodium and the streptomycin sulfate that the final concentration is 200IU, the pH value is adjusted to 7.3), the porcine transmissible gastroenteritis virus The seed virus of the Sinovirus strain was inoculated into the well-grown monolayer of the above-mentioned cells at a volume ratio of 5%, and the culture was continued at a temperature of 35°C. Harvest the virus liquid when more than 80% of the cells are diseased; measure the TCID 50 of the virus, and stop rejuvenation when the virus titer is stable and reaches more than 10 7 TCID 50 /mL, and use the virus as a seed virus for production.

(5)vero细胞在转瓶中的培养:取方瓶上生长良好的vero细胞用pH值为7.2的PBS清洗一遍,加入所述的EDTA-胰酶消化液消化,待细胞层开始出现整片脱落,加入所述的细胞生长液,吹悬制成细胞悬浮液,细胞计数密度按3×105/mL接种3000mL转瓶,转瓶培养量为300mL,37℃,20rpm/h,培养至细胞长成单层。(5) Cultivation of vero cells in spinner flasks: Take the well-grown vero cells on the square bottle and wash them with PBS with a pH value of 7.2, add the EDTA-trypsin digestion solution to digest, and wait until the cell layer begins to appear as a whole After falling off, add the above-mentioned cell growth solution, blow suspension to make a cell suspension, and inoculate a 3000mL spinner bottle with a cell count density of 3×10 5 /mL, with a culture volume of 300mL in the spinner bottle, 37°C, 20rpm/h, and culture until the cells Grow in a single layer.

(6)制苗毒液的繁殖:培养后第三日待观察,转瓶壁上细胞基本长满(95%以上),且细胞计数结果达5×106/mL以上后进行病毒接种。按体积比为2%的接种量接种病毒,4天后收获病毒上清液。收获病毒液的处理:收获上清经3次反复冻融后,过滤去除细胞碎片后-20℃冷冻保存备用。(6) Propagation of seedling venom: observe on the third day after culture, the cells on the spinner bottle wall are basically overgrown (more than 95%), and the virus inoculation is carried out after the cell count result reaches more than 5×10 6 /mL. The virus was inoculated at an inoculum volume ratio of 2%, and the virus supernatant was harvested 4 days later. Processing of harvested virus liquid: after 3 times of repeated freezing and thawing, the harvested supernatant was filtered to remove cell debris and then frozen at -20°C for later use.

试验例1半成品检验Test example 1 Semi-finished product inspection

1.收获病毒液毒价的测定:将以上收获的细胞病毒液混合后取样,测定毒价。1. Determination of the poisonous value of the harvested virus liquid: the cell virus liquid harvested above is mixed and then sampled, and the poisonous value is determined.

结果表明,实施例1和2用生物反应器生产的病毒的病毒含量≥107TCID50/mL,而对比例1转瓶培养生产的病毒含量≤106TCID50/mL。The results showed that the virus content of the virus produced by the bioreactor in Examples 1 and 2 was ≥10 7 TCID 50 /mL, while the virus content of the comparative example 1 produced by spinner bottle culture was ≤10 6 TCID 50 /mL.

2.灭活后半成品检验2. Inspection of semi-finished products after inactivation

灭活:按总量的0.2%向实施例1~2和对比例1的病毒液中加入甲醛溶液,振摇2分钟,置37℃条件灭活24小时,期间定时搅拌混匀。Inactivation: Add formaldehyde solution to the virus liquids of Examples 1-2 and Comparative Example 1 at 0.2% of the total amount, shake for 2 minutes, and inactivate at 37° C. for 24 hours, stirring and mixing regularly during this period.

无菌检验:按《中华人民共和国兽用生物制品质量标准》附录301页进行,本发明实施例和对比例的病毒均无菌生长。Sterility test: According to the appendix 301 page of the "Quality Standards for Veterinary Biological Products of the People's Republic of China", the viruses of the examples of the present invention and the comparative examples grew aseptically.

灭活检验:灭活后,以无菌操作从病毒灭活液中取样,按1%比例接种健康ST细胞单层,37℃培养3天,按此方法,连续传代3代,细胞不应出现病变为合格,本发明实施例和对比例均无病变,故产品合格。Inactivation test: After inactivation, take a sample from the virus inactivation solution by aseptic operation, inoculate a single layer of healthy ST cells at a ratio of 1%, and culture it at 37°C for 3 days. Pathological changes are qualified, and embodiment of the present invention and comparative example all have no pathological changes, so product is qualified.

3.生物反应器培养病毒与转瓶培养病毒免疫效果的比较3. Comparison of the immune effects of virus cultured in bioreactors and spinner bottles

各取200μL效价为1×106/mL的病毒免疫无TGEV中和抗体的仔猪各二十头,以200μL病毒培养液作为空白对照,结果生物反应器培养病毒免疫组的中和抗体效价比转瓶培养的高4倍,结果如下表。Take 200 μL of virus with a titer of 1×10 6 /mL to immunize twenty piglets without TGEV neutralizing antibodies, and use 200 μL of virus culture solution as a blank control. 4 times higher than that of spinner bottle culture, the results are shown in the following table.

表1生物反应器培养病毒与转瓶培养病毒免疫效果的比较Table 1 Comparison of the immune effects of virus cultured in bioreactors and in spinner bottles

以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明技术原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention, it should be pointed out that for those of ordinary skill in the art, without departing from the technical principle of the present invention, some improvements and modifications can also be made. These improvements and modifications It should also be regarded as the protection scope of the present invention.

Claims (5)

1. utilize bio-reactor to produce a method for transmissible gastro-enteritis virus, it is characterized in that, comprise the steps:
1) individual layer passage cell is prepared;
2) transmissible gastro-enteritis virus production kind of poison is prepared, specifically comprise the steps: with virus-culturing fluid transmissible gastro-enteritis virus kind poison to be inoculated in individual layer passage cell in 2-5% ratio to cultivate, gather in the crops virus liquid to during cell more than 80% pathology; Again using this virus liquid as kind of a poison, cell carries out cell adaptation continuous passage rejuvenation, and the product that at every turn goes down to posterity carries out viral TCID 50and Sterility testing, reach viral TCID 50stablize and reach 10 7tCID 50rejuvenation is stopped, as production kind of a poison during/more than mL;
3) before cell suspension inoculation to bio-reactor, steril cell growth media is added by the 50-70% of bio-reactor cumulative volume, and add microcarrier by 4-10g/L concentration in often liter of steril cell growth media, start bio-reactor, 20-50 minute is stirred in the slow speed of revolution, by step 1) after the individual layer passage cell EDTA-trysinization liquid prepared digests, suspend with cell growth medium, being prepared into cell density is 1-3 × 10 5the cell suspension of individual/mL, be inoculated in bio-reactor, absorption on the microcarrier of passage cell in bio-reactor is cultivated, described EDTA-trysinization liquid is be Hank ' the S liquid of the pancreatin of 0.05%-0.25% and the EDTA of 0.02% containing quality volume fraction, the formula of described cell growth medium is: massfraction is 95%-98%MEM liquid, 2%-5% bovine serum, final concentration is the antibiotic of 100-200IU/mL, pH value is 6.8-7.5, the parameter of bio-reactor setting is: culture temperature 35-38 DEG C, pH value 6.8-7.5, dissolved oxygen 50%-70%, stirring velocity 50-80rpm,
4) when passage cell grows to the 80%-90% of microcarrier, empty ball rate is lower than 5%, and full ball rate is greater than 80%, and cell counting reaches 3-5 × 10 6individual/more than mL time, the inoculum size inoculation step 2 with 2-5%) prepare kind poison, carry out virus absorption cultivate;
5) when passage cell more than 80% pathology on microcarrier, results virus liquid.
2. method according to claim 1, is characterized in that, also comprises and to be carried out by microcarrier before microcarrier joined cell growth medium cleaning and the step of sterilizing, be followed successively by with PBS immersion microcarrier more than 3 hours; Microcarrier 3-5 time is cleaned with PBS; Microcarrier is soaked, 121 DEG C of steam sterilizing 20-50min with PBS.
3. method according to claim 1 and 2, is characterized in that, described passage cell is ST cell or vero cell.
4. method according to claim 1 and 2, is characterized in that, described transmissible gastro-enteritis virus is floating plumage vaccine strain, h-5 vaccine strain or magnificent strain.
5. method according to claim 1 and 2, it is characterized in that, described microcarrier is Gelatin based Macroporous Microcarriers, polystyrene microcarrier, PHEMA microcarrier, chitin microcarrier, polyurethane foam microcarrier, alginate jelly microcarrier, magnetic microcarrier, Cytodex1, Cytodex2, Cytodex3, Cytopore and/or Cytoline.
CN201210141452.2A 2012-05-08 2012-05-08 A kind of method utilizing bio-reactor to produce transmissible gastro-enteritis virus Active CN102660510B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210141452.2A CN102660510B (en) 2012-05-08 2012-05-08 A kind of method utilizing bio-reactor to produce transmissible gastro-enteritis virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210141452.2A CN102660510B (en) 2012-05-08 2012-05-08 A kind of method utilizing bio-reactor to produce transmissible gastro-enteritis virus

Publications (2)

Publication Number Publication Date
CN102660510A CN102660510A (en) 2012-09-12
CN102660510B true CN102660510B (en) 2016-01-13

Family

ID=46770090

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210141452.2A Active CN102660510B (en) 2012-05-08 2012-05-08 A kind of method utilizing bio-reactor to produce transmissible gastro-enteritis virus

Country Status (1)

Country Link
CN (1) CN102660510B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103550771B (en) * 2013-10-31 2016-05-25 成都天邦生物制品有限公司 The production method of transmissible gastro-enteritis virus vaccine
CN103877571A (en) * 2014-03-21 2014-06-25 吉林正业生物制品股份有限公司 Preparation method and product of swine transmissible gastroenteritis inactivated vaccine
US11667906B2 (en) 2014-11-24 2023-06-06 Corning Incorporated Magnetic microcarriers
CN104651320A (en) * 2015-03-05 2015-05-27 成都天邦生物制品有限公司 Method for producing porcine transmissible gastroenteritis Hua strain virus by low-serum culture of ST cells
CN105400743A (en) * 2015-12-08 2016-03-16 天津瑞普生物技术股份有限公司 Preparation method of TGEV
CN106754749B (en) * 2016-12-14 2019-12-10 四川省华派生物制药有限公司 Method for improving virus content of virus liquid by adopting cell culture process twice

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1680433A (en) * 2005-02-04 2005-10-12 东北农业大学 Porcine transmissible gastroenteritis recombinant N protein antigen and its purification method
CN101491643A (en) * 2005-09-29 2009-07-29 贵州百祥制药有限责任公司 Medicine preparation for treating cancer and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1680433A (en) * 2005-02-04 2005-10-12 东北农业大学 Porcine transmissible gastroenteritis recombinant N protein antigen and its purification method
CN101491643A (en) * 2005-09-29 2009-07-29 贵州百祥制药有限责任公司 Medicine preparation for treating cancer and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
应用微载体技术生产TGEV试验研究;邹勇 等;《第六次全国会员代表大会暨第11次学术研讨会论文集(下)》;20050930;摘要,第2.2.3节,第2.3.2节,第2.3.1节,第2.2.2节,第1.2节,第2.2.1节 *

Also Published As

Publication number Publication date
CN102660510A (en) 2012-09-12

Similar Documents

Publication Publication Date Title
CN102660510B (en) A kind of method utilizing bio-reactor to produce transmissible gastro-enteritis virus
CN102091329B (en) Preparation method of inactivated porcine parvovirus vaccine and product thereof
CN101748102B (en) Method for production of porcine epidemic diarrhea virus
CN110272864A (en) A kind of Vero33 cell strain adapting to serum free suspension culture and its acclimation method and application
CN107460156B (en) Serum-free whole suspension MDCK cell line and its application in the production of influenza virus
CN101979519A (en) Method for preparing pseudorabies vaccines
CN103394081B (en) WAVE wave bioreactor is utilized to produce the method for avian influenza vaccine
CN101955915B (en) Method for producing influenza virus vaccine
CN103550771A (en) Production method of transmissible gastroenteritis virus vaccine
CN104004720B (en) A kind of large scale and high density produces the method for porcine circovirus 2 type antigen
CN104027798B (en) Method for culturing and producing PVC 2 antigen through whole suspension cells
CN103520715B (en) Method for producing porcine circovirus II type inactivated vaccine by utilizing WAVE bioreactor
CN105816869A (en) Preparation method of mink canine distemper virus live vaccine and vaccine prepared by same
CN102002481B (en) Production method of porcine reproductive and respiratory syndrome virus
CN101775374B (en) Production method of porcine epidemic diarrhea virus
CN105838683A (en) Method for proliferation of mink canine distemper virus by applying novel cell microcarrier
CN103550772B (en) Production method of pseudorabies virus vaccine
CN103614333A (en) Method for enlarging cultivation of zooblasts in reactor via collagen microcarriers
CN102727878A (en) Preparation method of porcine reproductive and respiratory syndrome inactivated vaccine (NVDC-JXA1 strain) by bioreactor and application thereof
CN105816872A (en) Preparation method of mink parvoviral enteritis inactivated vaccine and vaccine prepared by using same
CN102657859A (en) Method for producing avian influenza vaccine by using cells cultured by spherical microcarrier bioreactor
CN108853489B (en) A method of PEDV attenuated vaccine is produced using serum free medium
CN109666653B (en) Subculture method of rabies vaccine virus and preparation method of rabies vaccine
CN105368794A (en) Method of utilizing stirred bioreactor to produce infectious Bursal disease virus
CN103614344A (en) Method for amplifying porcine circovirus type 2 by applying bioreactor and flaky vector

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 100080 Beijing City, Haidian District Zhongguancun street, No. 27 Zhongguancun building 14 DaBeiNong group

Co-patentee after: Zhaofenghua Biotechnology (Fuzhou) Co.,Ltd.

Patentee after: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd.

Address before: 100080 Beijing City, Haidian District Zhongguancun street, No. 27 Zhongguancun building 14 DaBeiNong group

Co-patentee before: FUZHOU DA BEI NONG BIOTECH Co.,Ltd.

Patentee before: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200629

Address after: 211102, 999 Ting Dong Road, Jiangning economic and Technological Development Zone, Nanjing, Jiangsu

Co-patentee after: Zhaofenghua Biotechnology (Fuzhou) Co.,Ltd.

Patentee after: Zhaofenghua Biotechnology (Nanjing) Co.,Ltd.

Address before: 100080 Beijing City, Haidian District Zhongguancun street, No. 27 Zhongguancun building 14 DaBeiNong group

Co-patentee before: Zhaofenghua Biotechnology (Fuzhou) Co.,Ltd.

Patentee before: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd.